US Zika Vaccine Begins to Be Tested on Humans

Another vaccine against Zika virus will begin to be tested in humans. This is a formula that uses DNA from the virus and was developed by the US National Institute of Allergy and Infectious Diseases (NIAID).

At this stage of testing it was applied to 80 American volunteers aged 18-35. Patients received the first dose this Tuesday (2). The goal is to see if this vaccine is safe for humans and also to evaluate the immunization response with the vaccine.

In a press conference, NIAID director Anthony Fauci said the first results should be available by the end of 2016 "If the response has been satisfactory to clinical trials, phase two could be started in countries endemic for the Zika virus in 2017.

The United States is increasingly concerned about the Zika virus epidemic, due to cases related to sexual transmission throughout the country, and new cases of local mosquito transmission in Florida.

Prior to this, partner laboratories Inovio (from the United States) and GeneOne Life Sciences (South Korea) also began human trials of a vaccine against Zika virus.

Visit to the dentist helps protect the heart

Keeping your teeth clean, as well as tackling oral problems, helps protect the heart from heart attacks, says a study by scientists at the University of Miami and the Veterans General Hospital in Taiwan. According to those responsible for the analysis, many people do not care much about oral health because they think that gums and gums do not cause more harmful effects to the body and can be treated with ease.

(Health)

Anvisa alerts women with hepatitis C over contraceptives

According to the agency, women using this medicine should not use oral contraceptives containing ethinylestradiol, a semisynthetic hormone. The communication aims to warn health professionals and patients about the risks of serious adverse reactions arising from the interaction between the two drugs.

(Health)